Jeremy L. Schieler, Ph.D. - Publications
Affiliations: | 2006 | Purdue University, West Lafayette, IN, United States |
Area:
Parkinson’s disease, protein aggregationYear | Citation | Score | |||
---|---|---|---|---|---|
2008 | Liu F, Hindupur J, Nguyen JL, Ruf KJ, Zhu J, Schieler JL, Bonham CC, Wood KV, Davisson VJ, Rochet JC. Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults. Free Radical Biology & Medicine. 45: 242-55. PMID 18456002 DOI: 10.1016/J.Freeradbiomed.2008.03.022 | 0.537 | |||
2008 | Rochet JC, Schieler JL. The use of Cell-Free Systems to Characterize Parkinson's Disease-Related Gene Products Parkinson's Disease. 597-627. DOI: 10.1016/B978-0-12-374028-1.00043-9 | 0.451 | |||
2007 | Cambrea LR, Haque F, Schieler JL, Rochet JC, Hovis JS. Effect of ions on the organization of phosphatidylcholine/phosphatidic acid bilayers. Biophysical Journal. 93: 1630-8. PMID 17483164 DOI: 10.1529/Biophysj.107.104224 | 0.385 | |||
2006 | Mirzaei H, Schieler JL, Rochet JC, Regnier F. Identification of rotenone-induced modifications in alpha-synuclein using affinity pull-down and tandem mass spectrometry. Analytical Chemistry. 78: 2422-31. PMID 16579629 DOI: 10.1021/Ac051978N | 0.509 | |||
2006 | Schieler J, Liu F, Mirzaei H, Bernas T, Robinson J, Regnier F, Rochet J. Effect of oxidative stress on α-synuclein aggregation in Parkinson's disease Nanomedicine: Nanotechnology, Biology and Medicine. 2: 317. DOI: 10.1016/J.Nano.2006.10.152 | 0.529 | |||
2006 | Schieler JL, Liu F, Mirzaei H, Bernas TS, Robinson JP, Regnier FE, Rochet JC. 4 Saturday, September 9th (10:35)Concurrent Symposium I: Clinical NanomedicineEffect of oxidative stress on α-synuclein aggregation in Parkinson's disease Nanomedicine: Nanotechnology, Biology and Medicine. 2. DOI: 10.1016/J.Nano.2006.10.010 | 0.502 | |||
Show low-probability matches. |